[{"Assets_0_FY_USD":456789000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":45631000.0,"RevenuesConverted_4_FY_USD":206547000.0,"RevenuesConverted_1_FY_USD":47966000.0,"StockholdersEquity_0_FY_USD":212791000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":12040000.0,"EarningsPerShareBasic_4_FY_USD":0.51,"EarningsPerShareBasic_1_FY_USD":-0.41,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":11841000.0,"NetIncomeLossConverted_4_FY_USD":5997000.0,"EarningsPerShareDiluted_4_FY_USD":0.5,"EarningsPerShareDiluted_1_FY_USD":-0.41,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200227"}]